TB & Outbreaks Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB & Outbreaks Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cystic Fibrosis Therapy
Reports from Papworth Hospital, Department of Microbiology highlight recent research in cystic fibrosis therapy
March 17th, 2009
Fresh data on cystic fibrosis are presented in the report 'Recent advances in the microbiology of respiratory tract infection in cystic fibrosis.' According to a study from Papworth Everard, the United Kingdom, "Infection is a major cause of morbidity and mortality in patients with cystic fibrosis (CF). Research on CF infection has highlighted differences from other respiratory infections--both in the range and the nature of the organisms--especially in chronic infection." "This is a rapidly advancing field of microbiology and is bringing insights into the complexity and adaptations of bacteria causing chronic infection in the respiratory tract. AREAS OF AGREEMENT AND...
Source: TB & Outbreaks Week (2009-03-17)
|
